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1. Introduction 
 
α1,6-Fucosyltransferase (Fut8) transfers a fucose residue from GDP-fucose to the 
innermost N-acetylglucosamine (GlcNAc) residue 
via α1,6-linkage to form α1,6-fucosylation (1), 
which is referred to as core fucosylation in 
mammals (2, 3) (Fig.1). In fact, N-glycans with 
core fucosylation are widely distributed in a variety 
of glycoproteins, and then regulate functions in 
different manners. Accumulating data suggests that 
Fut8 and its products play important roles in 
various physiological and pathological processes, 
such as tumor formation (4, 5), inflammation and 
immune response (6-9), and central nervous 
system (CNS) diseases (10, 11). 
Fut8-deficient (Fut8
-/-
) mice exhibit a schizophrenia-like phenotype with a decrease in 
working memory (10) and long-term potentiation (12). Very recently, a complete loss of 
core fucosylation in patients was reported (13). Those patients showed growth 
retardation, severe developmental and growth delays and also including neurological 
impairment, which was quite similar to that seen in the phenotypes of Fut8
-/- 
mice (10, 
14). These data suggested core fucosylation plays important roles in the CNS. To 
explore the underlying mechanisms, we generated a Fut8 conditional knockout mouse 
using tamoxifen-inducible synapsin promoter-driven Cre recombinase. Surprisingly, the 
neuron-specific Fut8 conditional knockout mice did not show these phenotypes 
(unpublished data), suggesting there may be other cell types in the CNS that contribute 
to the schizophrenia-like behavior induced by the lack of core fucosylation. 
The pathophysiology of schizophrenia has not yet been fully elucidated. Studies 
involving in vivo imaging suggest that neuroinflammation may contribute to the 
Fig. 1 Biosynthesis of core fucose 
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pathogenesis of schizophrenia, which could be due to a dysfunction in glial cells (15, 
16). In the CNS, glial cells are made up mostly of microglia, astrocytes, and 
oligodendrocytes (Fig. 2). For several decades, many researchers believed that glial 
cells outnumbered neurons at a ratio of 10:1 (17), but recently researchers used isotropic  
fractionators to demonstrate that the ratio of glial cells to neurons is actually about 1:1 
(18). Anyway, glial cells are known to play crucial roles in neuronal functions (19, 20). 
As the only resident macrophage-like cells in the CNS, microglia are the pre-eminent 
form of active immune defense (21), even though they only account for 10-15% of all 
glial cells (22). In addition to their surveillance role, microglia participates in 
maintaining synapses and homeostasis in the CNS (23, 24). Astrocytes are the most 
abundant glial type, and make up ~20-40% (25). They provide trophic support for 
neurons (26), and also participate in the maintenance of synapses and in the process of 
neuroinflammation (27, 28). Oligodendrocytes coat axons in the CNS and produce the 
myelin sheath, which provides insulation to the axon that allows electrical signals to 
propagate more efficiently (29).  
Fig. 2 Main composition of glial cells in CNS 
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Microglial cells play a key role in neuroinflammation. After activation, microglia 
quickly release several pro-inflammatory mediators such as interleukin-1β (IL-1β), 
interleukin-6 (IL-6), and interferon gamma (IFN-γ), and induce reactive astrocytes, 
which leads to the further injury of neurons (28). In fact, postmortem studies have 
discovered a higher level of activation and increased microglia density in schizophrenia 
(30). Gene-set analyses have also shown that genetic alterations of astrocytes could 
increase the risk for schizophrenia (31). These results suggest the potential role of 
microglia and astrocytes in this disorder. 
Recently, several studies have also demonstrated that N-glycosylation might play 
important roles in schizophrenia. Postmortem examinations of the cortex of 
schizophrenia patients have shown alterations in the N-glycosylation of 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR), 
N-methyl-D-aspartate receptor (NMDAR) and γ-aminobutyric acid type A (GABAA) 
receptors (32-34). Furthermore, in the superior temporal gyrus of elderly patients with 
schizophrenia, the expression levels of Fut8 were decreased (35). 
The present study was focused on glial cells to explore the underlying mechanisms of 
the disorders found in the brains of Fut8
-/-
 mice. We found that the initial status of 
microglia and astrocytes activation and the neuroinflammation model induced by 
lipopolysaccharide (LPS) both were significantly enhanced in Fut8
-/-
 mice, compared 
with wild-type (Fut8
+/+
) mice. In accordance with the in vivo data, the sensitivities to 
inflammatory stimulators such as IFN-γ or IL-6 were greatly increased in glial cell lines 
lacking Fut8 (Fut8 KO cells) or primary astrocyte cells treated with 2-fluoro-L-fucose 
(2FF) (36-38), a fluorinated analog of fucose, which could dramatically inhibit 
fucosylation in cells, compared with those in wild-type (WT) cells. Along with previous 
results (10-12), these data clearly demonstrate the importance of Fut8 in microglia and 
astrocytes, and the disorders of Fut8
-/-
 mice are caused not only by neurons but also by 
glial cell dysfunction. 
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2. Materials and methods 
 
2.1. Materials 
The experiments were performed using the following antibodies: mouse mAb against 
inducible nitric oxide synthase (iNOS) (ab49999) and goat pAb against ionized calcium 
binding adaptor molecule 1 (Iba-1) (ab5076) were purchased from Abcam; rabbit pAb 
against Iba-1 (019-19741) was from Wako, Japan; mouse mAb against glial fibrillary 
acidic protein (GFAP) (MAB360) was from Millipore Corporation; mouse mAb against 
signal transducer and activator of transcription 3 (STAT3) (9139S), rabbit mAb against 
p-STAT3 Tyr705 (9145S), mouse mAb against Smad2 (3103S), rabbit mAb against 
p-Smad2 Ser465/467 (3108S), rabbit mAb against signal transducer and activator of 
transcription 1 (STAT1) (14994S), and rabbit mAb against p-STAT1 Tyr701 (9167S) 
were purchased from Cell Signaling Technology; mouse mAb against gp130 
(MAB5029) was from R&D Systems; mouse mAb against α-tubulin (T6199) was from 
Sigma and rabbit pAb against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
(sc-25778) was from Santa Cruz.  
Biotinylated Aleuria Aurantia Lectin (AAL), concanavalin A (ConA), sambucus nigra 
lectin (SNA) and maackia amurensis lectin (MAA) were obtained from J-oil Mills 
(Tokyo, Japan). Biotinylated Pholiota Squarrosa Lectin (PhoSL) was a generous gift 
from Dr. Yuka Kobayashi (J-oil Mills, Tokyo, Japan).  
The peroxidase-conjugated goat against mouse and rabbit IgG antibodies, and donkey 
against sheep/goat IgG antibody were obtained from Promega, Cell Signaling 
Technology and Millipore Corporation, respectively. Goat anti-mouse IgG Alexa Fluor 
568, goat anti-rabbit IgG Alexa Fluor 488, streptavidin-conjugate Alexa Fluor 647 were 
purchased from Invitrogen. 4',6-Diamidino-2-phenylindole Dihydrochloride n-Hydrate 
(DAPI) was obtained from Wako, Japan.  
LPS purified from Escherichia coli 0111:B4 was the product of Sigma, recombinant 
mouse IFN-γ was purchased from Prospec Bio, recombinant rat IL-6 was purchased 
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from PEPROTECH, and 2FF was purchased from Synchem, Inc., IL, USA. 
 
2.2. Animals  
The generation of Fut8
-/-
 mice by a gene-targeting technique has been described 
previously (10). ICR genetic background F1 heterozygous mice were mated with 
JF1/Ms (Japanese fancy mouse 1, M. m. molossinus–derived inbred strains) (39) mice 
to produce F2 generation mice, and the F2 generation mice were paired with other F2 
generation mice to generate the Fut8
-/-
 mice. All experiments were conducted with male 
and female mice 5~6 weeks old. Mice were housed in groups in each cage under 
conditions of constant temperature (22 ± 2°C) and humidity (55 ± 5%) on a 12-h 
light-dark cycle (lights on: 07:00 - 19:00) with free access to food and water. All animal 
experiments were performed in accordance with protocols approved by the Animal Care 
and Use Committee of the Graduate School of Pharmaceutical Sciences, Tohoku 
Medical and Pharmaceutical University.  
 
2.3. Cell culture 
Mouse microglia cell line BV-2 was kindly provided by Professor Elisabetta Blasi 
(University of Modena and Reggio Emilia, Modena, Italy). Rat glioma cell line C6 was 
purchased from American Type Culture Collection (Rockville, MD, USA). Cells were 
cultured in Dulbecco’s modified Eagle Medium (DMEM) containing 10% fetal bovine 
serum (FBS) and incubated at 37 °C in a humidified atmosphere with 5% CO2. The 
medium was replaced every 3 days. 
Mouse primary cells from brain tissues were prepared as previously reported with some 
modifications (40). Briefly, newborn (day 0-1) ICR Fut8
+/+
 mice were euthanized by 
decapitation using scissors, the cortex was removed, and cut into pieces on ice, and then 
digested with 0.125% trypsin for 20 min at 37 °C. A 100 μm Nylon (Falcon) cell 
strainer was used to filter the undigested tissue. This procedure was followed by 
centrifugation at 300 g for 5 min, and then the cells were re-suspended and plated on 
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poly-D-lysine (PDL, 50 μg/mL)-coated culture flasks. Single-cell suspensions were 
cultured in DMEM/F12 supplemented with 10% FBS and 1% penicillin-streptomycin 
(100 U/mL). The medium was replaced with fresh medium after 24 h and changed 
every 3 days. In order to isolate the primary microglia, after 14 days, the mixed cells 
were shaken gently at 180 rpm for 2 h at 37 °C, and then the supernatants containing 
microglia were collected and plated on the new PDL-coated culture dishes. The 
remaining cells were washed with phosphate buffered saline (PBS), and then detached 
with 0.25% trypsin to obtain the primary astrocytes. After centrifuge, the primary 
astrocytes were also cultured in PDL-coated culture dishes. All cells were maintained in 
a 37 °C incubator containing 95% air and 5% CO2. Immunofluorescent staining with 
Iba-1 and GFAP antibodies was used to differentiate the microglia and astrocytes. The 
purity of both the microglia and astrocytes was more than 90%. 
 
2.4. Immunofluorescence 
After intraperitoneal injection with LPS (1 mg/kg) for 24 h, animals were deeply 
anesthetized with sodium pentobarbital and intracardially perfused with 50 ml of PBS, 
followed by 50 ml of 4% paraformaldehyde (PFA; Sigma-Aldrich) in 0.1 M PBS. 
Brains were post-fixed in 4% PFA-0.1 M PBS at 4 °C overnight, followed by 
immersion in 20% sucrose-0.1 M PBS for 48 h. The brains were cut into 40 μm sections 
that included the dorsal dentate gyrus from bregma -1.60 mm to -2.60 mm using a 
cryostat (MICROM HM560, Microm International GmbH, Walldorf, Germany). Frozen 
sections were mounted on glass slides (Matsunami Glass, Japan). The sections were 
incubated with PBS containing 1% normal goat serum and 0.3% Triton X-100 (PBSGT) 
at room temperature for 2 h. The sections were incubated overnight at 4 °C with rabbit 
anti-Iba1 (1:200) and mouse anti-GFAP (1:200) antibodies. Sections were washed 3 
times with PBS every 10 min, then incubated with goat anti-mouse IgG Alexa Fluor 568 
(1:500) and goat anti-rabbit IgG Alexa Fluor 488 (1:500) in PBSGT for 2 h at room 
temperature. Finally, sections were washed 3 times with PBS every 10 min and 
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coverslipped with fluorescent mounting medium (Dako, Carpinteria, CA, USA). 
Immunofluorescent images were analyzed using a confocal laser-scanning microscope 
(A1Rsi: Nikon, Tokyo, Japan). The number of Iba-1 positive cells in the images (0.04 
cm
2
) and the length of each soma radius were measured using NIS-Elements AR 
Analysis (Nikon, Tokyo, Japan), the area of superficial somas was then calculated by 
following the equation (4πR2). 
 
2.5. Generation of CRISPR/Cas9-based Fut8- KO Cells 
The CRISPR/Cas9-based Fut8-KO cells were established, as described previously (41). 
Briefly, the sgRNA-specifying oligo sequences (sequences one: 
5’-CACCGCAGAATTGGCGCTATGCTAC-3’ and 
5’-AAACGTAGCATAGCGCCAATTCTGC-3’; sequences two: 
5’-CACCGATTCGTCCACAACCTTGGC-3’ and 
5’-AAACGCCAAGGTTGTGGACGAATC-3’) spanning Mus musculus 
fucosyltransferase 8 (NM_001252614) and the sgRNA-specifying oligo sequences 
(sequences one: 5’-CACCGGAGATAAGTTATTCTCCGC-3’ and 
5’-AAACGCGGAGAATAACTTATCTCC-3’; sequences two: 
5’-CACCGATTTGATTCGTCCACAACCT-3’ and 
5’-AAACAGGTTGTGGACGAATCAAATC-3’) spanning rattus norvegicus 
fucosyltransferase 8 (NM_001002289.1) were cloned into the pSpCas9 (BB)-2A-GFP 
(Addgene plasmid ID: 48138) vector (41), which was a kind gift from Dr. Feng Zhang. 
The plasmid was electroincorporated into the BV-2 and C6 cells according to the 
manufacturer’s instructions (Amaxa® cell line Nucleofector R kit V). After 72 h of 
transfection, GFP-positive cells were sorted using the FACS Aria II (BD Bioscience). 
Cells that were Fut8 positive and GFP negative were sorted approximately three times 
using PhoSL during the following 3-week culture. The Fut8-KO cells were confirmed 
by flow cytometric and lectin blotting analyses, as described in the following section.  
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2.6. Flow cytometric analysis 
Cells were grown to ~80% confluency, then detached from culture dishes, washed with 
ice-cold PBS, and subsequently stained with biotinylated PhoSL for 1 h on ice, followed 
by incubation with streptavidin-conjugate Alexa Fluor 647 for 1 h on ice in the dark. A 
negative control was prepared only with streptavidin-conjugate Alexa Fluor 647. During 
incubation, the cells were gently mixed every 10 min by flicking. Finally, cells were 
washed 3 times with ice-cold PBS and analyzed via FACSCalibur flow cytometer (BD 
Biosciences). 
 
2.7. Western blot and lectin blot analyses 
The mice were euthanized by decapitation after 24 h of LPS (1 mg/kg) administration. 
Brain hippocampi were rapidly removed, placed on ice, and then homogenized in 4 
volumes of TBS (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% protease) with φ2.0 
Zirconia Beads by Micro Smash MS-100 (Digital Biology), according to the 
manufacturer’s instructions. After centrifugation at 8,000 rpm for 15 min, the 
supernatants were collected and used for analysis. 
Cells cultured under different conditions were washed with PBS and lysed with lysis 
buffer that contained 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton-X100, and 1% 
protease and phosphatase inhibitor cocktail (Nacalai Tesque, Japan). Protein 
concentrations were measured using a bicinchoninic acid protein assay kit (Thermo 
Fisher Scientific, Wilmington, DE, USA).  
Equal amounts of proteins were separated by sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis (SDS-PAGE) and then transferred to PVDF (Millipore, Billerica, 
MA, USA) membranes for future detection. For Western blot, after blocking with 5% 
skim milk or 3% bovine serum albumin (BSA) for 2 h at room temperature, the 
membranes were incubated with specific primary antibodies at 4 °C overnight, followed 
by incubation with appropriate horseradish peroxidase (HRP)-conjugated secondary 
antibody. For lectin blot, the membranes were blocked in 3% BSA overnight at 4 °C, 
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followed by incubation with biotinylated AAL, ConA, SNA or MAA lectin for 2 h at 
room temperature, and then the immunoreactive bands were probed with a Vectastain 
ABC kit (Vector Laboratories, Burlingame, CA, USA). Finally, specific proteins were 
visualized using an ECL select
TM
 reagent (Amersham, Piscataway, NJ, USA).  
 
2.8. Video microscope 
BV-2 Cells were plated at a density of 1×10
4
 in a glass-bottom dish (Asahi Glass, 
Shizuoka, Japan). After the cells attached over night, the culture media were replaced 
with fresh media without phenol red but with IFN-γ (20 ng/ml), and then cell motility 
was monitored for 12 h using Axio Vision (Carl Zeiss, Jena, Germany). Images were 
acquired using an inverted microscope (AxioObserver.D1; Carl Zeiss) every 10 min 
with 5% CO2 at 37 °C in a heated chamber equipped with temperature and CO2 
controllers (Onpu-4 and CO2; AR Brown, Tokyo, Japan) during time-lapse imaging. 
Cell migration was evaluated using an AxioVision Tracking module (Carl Zeiss). 
 
2.9. Immunoprecipitation 
After being washed with PBS, cells were treated with lysis buffer, as previously 
described. Anti-gp130 antibody and Ab-Capcher Protein A-R28 agarose (Protenova, 
Tokushima, Japan) were first mixed together for 1 h on ice, and then gently mixed again 
every 10 min. The cell lysates were then immunoprecipitated with the antibody-agarose 
solution for 1 h at 4 °C with rotation. The immunoprecipitates were then washed twice 
with TBS and subjected to SDS-PAGE. 
 
2.10. Statistical analysis 
Results are reported as the means ± S.E.M. Statistical analyses were performed using an 
unpaired Student’s t test with Welch’s correction or a one-way analysis of variance 
(ANOVA) with Tukey’s post hoc test by GraphPad Prism version 5. Statistical 
significance was defined as p < 0.05. 
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3. Results 
 
3.1. The basal status of microglia activation was increased in Fut8
-/-
 mice 
First, we checked the basal status of glial cell activation by detecting Iba-1 and GFAP, 
which are markers for microglia and astrocytes, respectively, in the hippocampus 
regions in vivo. The immunochemical staining with anti-Iba-1 antibody clearly showed 
that the Iba-1-positive cells were significantly increased in Fut8
-/-
 mice under normal 
conditions without treatment, compared with that of the Fut8
+/+
 mice (Fig. 3A and C). 
Interestingly, the number of Iba-1-positive cells in the Fut8
+/-
 mice fell between those of 
both the Fut8
+/+
 and Fut8
-/-
 mice, which may have been due to the lower enzyme activity 
of Fut8. Furthermore, the sizes of the microglia, evaluated by the superficial area of the 
central soma, in Fut8
-/-
 mice were larger than those in the Fut8
+/+
 mice, while the sizes 
in the Fut8
+/-
 mice fell between those of both the Fut8
+/+
 and Fut8
-/-
 mice (Fig. 3A and 
D). These results suggest that the deficiency of Fut8 could have spontaneously 
increased the basal level of microglia activation in vivo. 
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Figure 3. Effects of core fucosylation on the activation of glial cells in mice brain 
tissues. Brain sections of mice were prepared and analyzed, as described in 
“Experimental procedures”. (A) The representative microscopy images immunostained 
with anti-Iba1 (green) antibodies, anti-GFAP (red) antibodies, and DAPI (blue) in the 
hippocampus of brain tissues of mice under normal conditions; (B) The representative 
microscopy images after the administration of LPS by intraperitoneal injection (i.p. 1 
mg/kg, 24 h). (C) Quantification of Iba-1 positive cells using representative tissue 
sections stained with anti-Iba1 antibody. Data represent the mean ± S.E.M.; p values 
were calculated using one-way ANOVA with Tukey’s multiple comparison test. *p < 
0.05 vs. Fut8
+/+
 mice (n=3, n: number of slices; N=3, N: number of the mice per group). 
(D) Quantification of microglia soma size using representative tissue sections stained 
with anti-Iba1 antibody. Data represent the mean ± S.E.M.; p values were calculated 
using one-way ANOVA with Tukey’s multiple comparison test. **p < 0.01 vs. Fut8+/+ 
mice (n=96, n: number of recordings; N=3, N: number of the mice per group). 
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3.2. Microglia and astrocytes of Fut8
-/-
 showed a greater level of sensitivity to LPS 
It is well known that neuroinflammation is a common pathological change in many 
disorders of the CNS such as Alzheimer's disease (42) and Parkinson's disease (43), and 
that it also could participate in the pathology of schizophrenia (44). Here, we 
established a systemic inflammatory model induced by a low dose of LPS at 1 mg/kg 
via intraperitoneal injection, as described in “Experimental procedures”. The 
immunochemical staining of brain tissues with anti-Iba-1 antibody showed greater 
increase in microglia activation, which included both numbers and sizes in Fut8
-/-
 mice, 
compared with those in Fut8
+/-
 and Fut8
+/+
 mice (Fig. 3B, C and D). Consistent with the 
immunohistochemical analysis, Western blot analysis has shown that without LPS 
treatment the basal expression levels of Iba-1 are increased in both Fut8
-/-
 and Fut8
+/-
 
mice, compared with that in Fut8
+/+
 mice (Fig. 4A, B), and the injection of LPS greatly 
increased the expression levels of Iba-1 in the Fut8
-/-
 and Fut8
+/-
 mice, but only 
modestly increased the levels in Fut8
+/+
 mice (Fig. 4A, B). Western blot analysis also 
showed a significantly increased expression of GFAP in both untreated and LPS-treated 
Fut8
-/-
 and Fut8
+/-
 mice, compared with Fut8
+/+
 mice (Fig. 4A, C). These results 
indicated that Fut8 may negatively regulate microglia and astrocytes responses to 
extrinsic stimuli during the process of neuroinflammation. 
It is worth mentioning that the inflammation induced by LPS increased the expression 
of fucosylation. The lectin blotting with AAL, which preferentially recognizes core 
fucose (45), showed an increase in both Fut8
+/-
 and Fut8
+/+
 mice brain tissues for 24 h 
following an injection of LPS. It is reasonable to speculate that specific reactive bands 
simply could not be detected in the Fut8
-/-
 mice (Fig. 4D).  
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Figure 4. Effects of LPS on fucosylation, and expression of Iba-1 and GFAP in mice 
brain tissues. Tissue lysates from mice hippocampi were prepared as described in 
“Experimental procedures”. (A) The expression levels of Iba-1 and GFAP were 
examined by Western blotting with anti-Iba-1 and anti-GFAP antibodies. GAPDH was 
used as a loading control. (B) Quantitative analysis of Iba-1 protein expression in 
normal and LPS-stimulated Fut8
+/+
 and Fut8
-/-
 mice. Data represent the mean ± S.E.M; 
p values were calculated using unpaired t test with Welch’s correction. **p < 0.01 vs. 
Fut8
+/+
 mice (n=3). (C) Quantitative analysis of GFAP protein expression in normal and 
LPS-stimulated Fut8
+/+
 and Fut8
-/-
 mice. Data represent the mean ± S.E.M; p values 
were calculated using unpaired t test with Welch’s correction. **p < 0.01 vs. Fut8+/+ 
mice (n=3). (D) The expression levels of fucosylation were detected by AAL lectin blot. 
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Asterisks indicate nonspecific bands. 
 
3.3. Neuroinflammation upregulated fucosylation expression in microglia 
We isolated primary microglial cells from Fut8
+/+
 mice brain tissues and stimulated 
them with a commonly used stimuli for inflammation, IFN-γ (46), which also shows an 
increased expression in schizophrenia patients (47). The IFN-γ stimulation consistently 
increased the expression of fucosylation detected by lectin blotting with AAL (Fig. 5A), 
and induced the expression of iNOS, which is an enzyme responsible for the 
inflammation-induced production of nitric oxide (NO) (48). To further confirm the 
effects of neuroinflammation on fucosylation expression in microglia, we used BV-2, a 
microglial cell line, as a cell model. The reactivity with AAL was also enhanced in a 
dose- (Fig. 5B) and time-dependent manner (Fig. 5C). The expression of iNOS induced 
by IFN-γ was observed at a final concentration at 10 ng/ml, and remarkably appeared at 
20 ng/ml (Fig. 5B). In addition, iNOS expression reached a peak at 24 h, after which it 
diminished (Fig. 5C). These data showed that neuroinflammation might upregulate the 
expression of fucosylation in microglia. 
Figure 5. Changes in fucosylation and iNOS expression in primary microglia cells 
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and in BV-2 cells treated with IFN-γ. (A) Primary microglia cells were prepared as 
described in “Experimental procedures”, and were then treated with IFN-γ (20 ng/ml) at 
the indicated times. Equal amounts of cell lysates were detected via AAL lectin blot 
(upper panel) and anti-iNOS antibody (middle panel). (B) BV-2 cells were treated with 
IFN-γ for 24 h at the indicated concentrations, and then harvested. The cell lysates were 
detected via AAL lectin blot (upper panel) and anti-iNOS antibody (middle panel). (C) 
BV-2 cells were treated with IFN-γ (20 ng/ml) at the indicated times, and then harvested 
for AAL lectin blot (upper panel) and anti-iNOS antibody (middle panel) testing. 
α-tubulin was used as a loading control. 
 
3.4. Established a core fucosylation-deficient BV-2 cell line 
To explore the roles of core fucosylation in microglia-mediated neuroinflammation, we 
established a core fucosylation-deficient BV-2 cell line using the CRISPR/Cas9 system 
described in “Experimental procedures”. The efficiency of Fut8 KO was confirmed by 
AAL blot analysis (Fig. 6A) and flow cytometric analysis stained with PhoSL, which 
specifically recognizes core fucosylated N-glycans (49) (Fig. 6E). These results clearly 
showed that core fucosylation was completely abolished in Fut8 KO cells. The results of 
ConA, SNA and MAA lectin blotting showed no significant differences between WT 
and KO cells (Fig. 6B, C and D), which suggested that only core fucosylation was 
specifically blocked. Here, we chose KO2 cells for the following experiments.  
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Figure 6. Established the Fut8 KO BV-2 cell line. The Fut8-deficient BV-2 cells were 
established using the CRISPR/Cas9 system, as described in “Experimental procedures”. 
(A) Equal amounts of cell lysates were detected by AAL lectin blot with α-tubulin used 
as the loading control. Asterisks indicate nonspecific bands. Equal amounts of cell 
lysates were detected by ConA lectin blot (B), SNA lectin blot (C), and MAA lectin blot 
(D). (E) The expression level of core fucosylation on the cell surface recognized by 
PhoSL, was analyzed via flow cytometry. 
 
3.5. Effects of Fut8 on IFN-γ stimulated neuroinflammation in BV-2 cells 
To explore the roles of core fucosylation in IFN-γ stimulated neuroinflammation, we 
detected the IFN-γ-stimulated signaling pathways in BV-2 WT and KO cells. Western 
blot assay revealed that IFN-γ induced iNOS expression with a dose-dependent manner 
in both the WT and KO cells. However, the induction of iNOS expression by IFN-γ at 
doses of both 10 ng/ml and 20 ng/ml was much higher in the KO cells, compared with 
that in WT cells (Fig. 7A, B). The time-course effects of IFN-γ at 20 ng/ml also clearly 
showed that the iNOS expression levels were higher in the KO cells, compared with 
those in WT cells (Fig. 7C, D). In addition, we used time-lapse microscopy to detect cell 
motility, which is known to indicate the activation of microglia after inflammatory 
stimulation. We found that those cells did not move under normal culture condition, 
while after IFN-γ stimulation, the cell motility was significantly increased in the KO 
cells (Fig. 7E).  
Consistently, the IFN-γ-induced phosphorylation levels of STAT1 in the KO cells were 
slightly higher than those in the WT cells (Fig. 7F, G). While examining the 
involvement of crosstalk between IFN-γ- and transforming growth factor β 
(TGF-β)-mediated signaling, a common anti-inflammatory cytokine (50, 51), we 
detected phosphorylation levels of Smad2, which is a specific TGF-β downstream 
signaling molecule. As shown in Fig. 7H and I, the expression of p-Smad2 was detected 
under stimulation with IFN-γ at 12 and 24 h in the WT cells, while it was undetectable 
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in the KO cells. These data indicated that a deficiency in Fut8 could increase the 
sensitivity of microglia to inflammatory stimulators and increase the inflammatory 
reaction while decrease the anti-inflammatory reaction. 
 
Figure 7. Effects of core fucosylation on cellular signaling and cell motility in BV-2 
cells treated with IFN-γ. (A) After cells were stimulated with IFN-γ at the indicated 
doses for 24 h, the expression levels of iNOS in both WT and KO cells were examined 
by Western blotting with anti-iNOS antibody. (B) Quantitative analysis of iNOS protein 
expression in IFN-γ-stimulated WT and KO cells. Data represent the mean ± S.E.M; p 
values were calculated using unpaired t test with Welch’s correction. *p < 0.05 vs. WT 
cells (n=3). (C) After cells were stimulated with IFN-γ at 20 ng/ml for the indicated 
time, the expression levels of iNOS in both WT and KO cells were examined by 
Western blotting with anti-iNOS antibody. (D) Quantitative analysis of iNOS protein 
expression in IFN-γ-stimulated WT and KO cells. Data represent the mean ± S.E.M; p 
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values were calculated using unpaired t test with Welch’s correction. *p < 0.05 vs. WT 
cells (n=3). (E) Cell motility of BV-2 cells was examined via video microscope, as 
described in “Experimental procedures”. The cell moving distances of both WT and KO 
cells were recorded during the stimulation with IFN-γ (20 ng/ml) for 12 h. Data 
represent the mean ± S.E.M; p values were calculated using unpaired t test with Welch’s 
correction. **p < 0.01 vs. WT cells (n=33, n: numbers of recording). (F) After cells 
were stimulated with IFN-γ (20 ng/ml) at the indicated times, the expression levels of 
phosphorylation for STAT1, a downstream signaling of IFN-γ, in both WT and KO cells 
were examined by Western blotting with anti-phospho-STAT1 antibody. Total STAT1 
was used as a loading control. (G) Quantitative analysis of p-STAT1 protein expression 
in IFN-γ-stimulated WT and KO cells. Data represent the mean ± S.E.M; p values were 
calculated using unpaired t test with Welch’s correction. *p < 0.05 vs. WT cells (n=3). 
(H) After cells were stimulated with IFN-γ (20 ng/ml) at indicated times, the expression 
levels of the phosphorylation of Smad2, a specific signaling of TGF-β, were examined 
by Western blotting in both WT and KO cells with anti-phospho-Smad2 antibody. Total 
Smad2 was used as a loading control. (I) Quantitative analysis of p-Smad2 protein 
expression in IFN-γ-stimulated WT and KO cells. Data represent the mean ± S.E.M; p 
values were calculated using unpaired t test with Welch’s correction. **p < 0.01 vs. WT 
cells (n=3). 
 
3.6. Effects of Fut8 expression on cellular signaling in primary astrocytes  
It is well known that astrocytes also participate in neuroinflammation (52). Thus, we 
isolated the primary astrocytes from the Fut8
+/+
 mice brain tissues, and treated them 
with or without 2FF. After treatment for 3 days, the inhibitory effects of 2FF were 
observed at a final concentration at 30 μM, and remarkably appeared at 100 μM (Fig. 
8A). IL-6 is an important inflammatory cytokine in schizophrenia (47), and the 
responses which it stimulates were compared between the cells. As shown in Fig. 8B 
and C, IL-6-mediated phosphorylation levels of STAT3 were higher in the 
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2FF-pretreated cells, compared with those in the control cells. 
 
Figure 8. Effects of 2FF on fucosylation and cellular signaling in primary 
astrocytes. (A) Primary astrocytes were prepared as described in “Experimental 
procedures”, and were cultured with 2FF, an inhibitor of fucosylation, for 3 days at the 
indicated concentrations. Equal amounts of cell lysates were detected by AAL lectin 
blot. α-Tubulin was used as a loading control. Asterisks indicate the nonspecific bands. 
(B) The primary astrocytes were pretreated with or without 2FF at 30 μM for 3 days, 
and then were further stimulated with or without IL-6 (10 ng/ml) at the indicated times. 
The expression levels of phosphorylated STAT3 in those cells were examined by 
Western blotting with anti-phospho-STAT3 antibody. Total STAT3 was used as a 
loading control. (C) Quantitative analysis of the effects of 2FF on p-STAT3 protein 
expression in IL-6-stimulated primary cells. Data represent the mean ± S.E.M; p values 
were calculated using unpaired t test with Welch’s correction. **p < 0.01 vs. control 
cells (n=3). 
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3.7. Effects of Fut8 expression on cellular signaling in C6 cell line 
To further explore the effect of Fut8 in astrocytes during neuroinflammation, we used 
glioma C6 cells as an astrocyte cell model. We established the Fut8-KO cells via the 
CRISPR/Cas9 system, which was confirmed by AAL lectin blotting (Fig. 9A) and flow 
cytometric analysis (Fig. 9B). We chose the KO2 cells for further experiments. 
Consistent with data obtained from primary astrocytes (Fig. 8), the responses stimulated 
by IL-6 in KO cells were sharper and stronger than those in the WT (Fig. 9C, D). When 
considering the core fucosylation influence on the functions of glycoproteins expressed 
on the cell surface, we attempted to detect whether these receptors were modified by 
core fucosylation. We found that glycoprotein 130 (gp130), one subunit of IL-6 receptor, 
contained core fucosylation as detected by AAL lectin in the WT cells, and the 
reactivity with AAL was abolished in the KO cells (Fig. 9E). 
 
Figure 9: Effects of core fucosylation on cellular signaling in C6 cells. Establishment 
of the Fut8 KO C6 cells was performed via a CRISPR/Cas9 system, as described in 
“Experimental procedures”. (A) Equal amounts of cell lysates were detected by AAL 
lectin blot. (B) The expression level of core fucosylation recognized by PhoSL on the 
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cell surfaces was subjected to flow cytometric analysis. (C) The expression levels of 
phosphorylated STAT3 in both WT and KO cells treated with or without IL-6 (10 ng/ml) 
stimulation at indicated times, were examined by Western blotting with 
anti-phospho-STAT3 antibody. Total STAT3 was used as a loading control. (D) 
Quantitative analysis of p-STAT3 protein expression in IL-6-stimulated C6 WT and KO 
cells. Data represent the mean ± S.E.M; p values were calculated using unpaired t test 
with Welch’s correction. *p < 0.05 vs. WT cells (n=3). (E) Equal amounts of cell lysates 
were immunoprecipitated (IP) with anti-gp130 antibody, which was followed by AAL 
lectin blot (upper panel). Whole cell lysates were directly blotted with anti-gp130 (as an 
input, middle panel) and α-tubulin (as a loading control, lower panel) antibodies.  
 
3.8. Effects of Fut8 on IL-6 stimulated BV-2 cells and IFN-γ stimulated C6 cells 
To further confirm the effect of core fucosylation on microglia and astrocytes, we 
examine the signaling pathways of IL-6 induced STAT3 signaling pathway in BV-2 cells 
and IFN-γ induced STAT1 signaling pathway in C6 cells. Consistent with data obtained 
from C6 cells, the IL-6-induced phosphorylation levels of STAT3 in the BV-2 KO cells 
were sharper and stronger than those in the WT (Fig. 10A, B). The responses of IFN-γ 
stimulated in C6 cells were also similar to those in BV-2 cells: the phosphorylation 
levels of STAT1 in C6 cells were slightly higher than those in WT cells (Fig. 10C, D). 
Depends on these data, we believe that glial cells, at least microglia and astrocytes, may 
share similar responses to IFN-γ and IL-6. 
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Figure 10: Effects of core fucosylation on IL-6-STAT3 signaling pathway in BV-2 
cells and IFN-γ-STAT1 signaling pathway in C6 cells. (A) After cells were stimulated 
with IL-6 (10 ng/ml) at the indicated times, the expression levels of phosphorylation for 
STAT3 in both WT and KO BV-2 cells were examined by Western blotting with 
anti-phospho-STAT3 antibody. Total STAT3 was used as a loading control. (B) 
Quantitative analysis of p-STAT3 protein expression in IL-6-stimulated WT and KO 
BV-2 cells. Data represent the mean ± S.E.M; p values were calculated using unpaired t 
test with Welch’s correction. *p < 0.05 vs. WT cells (n=3). (C) After cells were 
stimulated with IFN-γ (20 ng/ml) at the indicated times, the expression levels of 
phosphorylation for STAT1 in both WT and KO C6 cells were examined by Western 
blotting with anti-phospho-STAT1 antibody. Total STAT1 was used as a loading control. 
(D) Quantitative analysis of p-STAT1 protein expression in IFN-γ-stimulated WT and 
KO C6 cells. Data represent the mean ± S.E.M; p values were calculated using unpaired 
t test with Welch’s correction. *p < 0.05 vs. WT cells (n=3). 
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4. Discussion 
 
In the present study, we investigated the potential roles of core fucosylation involved in 
neuroinflammation, and found that a higher activation of microglia and astrocytes was 
observed in Fut8
-/-
 mice, compared with that in Fut8
+/+
 mice. The experiments using 
primary cells and cell models of microglia and astrocytes suggested that suppression of 
core fucosylation resulted in an increase in sensitivity for pro-inflammatory cytokines 
such as IFN-γ and IL-6. Furthermore, the results of mouse inflammatory models 
induced by LPS also showed that the response for LPS was greatly increased in the 
Fut8
-/-
 mice, compared with that in Fut8
+/+
 mice, although the responses were different 
from results obtained from mouse embryonic fibroblasts (53), which may be due to 
different cell types and the existence of blood-brain barrier. It is also worth noting that 
those responses in the Fut8
+/-
 mice always occurred on a level that fell between that of 
Fut8
-/-
 and Fut8
+/+
 mice. These results clearly suggest that core fucosylation negatively 
regulates the functions of microglia and astrocytes in neuroinflammation.  
Neuroinflammation could protect the CNS from harmful stimuli arising from both 
endogenous and exogenous substances in physiological conditions. However, 
uncontrolled or persistent neuroinflammation is potentially harmful and can result in 
cellular damage, which is particularly relevant to neurodegenerative diseases (54). 
Microglia cells are the first responders to infection or tissue injury, and often initiate the 
inflammatory response. Our data clearly showed that the microglia cells in Fut8
-/-
 mice 
exist in a spontaneously activated state, while those in Fut8
+/+
 mice are in a resting state 
under normal conditions (Fig. 3), which suggests the occurrence of persistent 
neuroinflammation in the Fut8
-/-
 mice. Further in vitro experiments have shown that a 
lack of core fucosylation could increase the response of the microglia cell line BV-2 to 
IFN-γ (Fig. 7). Astrocytes, together with microglia, also contribute to immune and 
inflammatory reactions in the CNS. In response to pro-inflammatory molecules 
including NO and reactive oxygen species released by microglial cells, astrocytes 
24 
 
become activated and secrete great amounts of cytokines (55). Our data also showed 
that the IL-6-mediated cellular signaling was greatly promoted by primary astrocytes 
treated with 2FF, an inhibitor of fucosylation, which was also confirmed by the deletion 
of Fut8 in glioma C6 cells (Fig. 8, 9). All these data indicated that deficiency of core 
fucosylation might increase the sensitivity of microglia and astrocytes to stimuli. It is 
also worth mentioning that both in vivo and in vitro experiments showed the increased 
expression of AAL after long-time inflammatory stimulation. This interesting phenotype 
may be due to a negative feedback of inflammation. 
We wondered why the sensitivity of microglia and astrocytes increases with a lack of 
core fucosylation. Although the underlying molecular mechanism remains unclear, the 
following scenario is plausible. First, a lack of core fucosylation on these cytokine 
receptors might enhance the interaction between a receptor and its ligand, and could 
promote several pro-inflammatory signaling (Fig. 11). Previous studies by our group 
and by those of other groups have indicated that many receptors expressed on the cell 
surface contain core fucose: TGF-β1 receptors (14, 56), epidermal growth factor (EGF) 
receptors (57, 58), T cell receptors (TCR) (6, 9), and integrin α3β1 (59). The present 
study found that gp130, an important transmembrane protein of IL-6 signaling 
complexes, also contain core fucose (Fig. 9). Loss of core fucose on activin receptors 
(11) and AMPARs, one type of ionotropic glutamate receptor, enhanced the formation 
of receptor complexes (12), which constitutively activated intracellular signaling. 
Interestingly, the results obtained from two independent analyses of the crystal 
structures of glycosylated Fc receptor FcγRIIIa and both the core fucosylated and 
unfucosylated Fc regions of immunoglobulin G (IgG) (60, 61) also supported these 
observations. Core fucose depletion can increase the incidence of the active 
conformation of the Tyr-296 of Fc, thereby accelerating the high-affinity 
heteromerization with its receptor. Those two independent studies clearly revealed why 
a lack of core fucosylation on IgG1 can dramatically enhance antibody-dependent 
cellular cytotoxicity activity (62, 63). The results of the present study showed an 
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enhancement of the IL-6-induced p-STAT3 signal pathway in Fut8 KO C6 cells (Fig. 9) 
as well as in the Fut8 KO BV-2 cells (Fig. 10), and the IFN-γ-induced p-STAT1 
signaling in Fut8 KO BV-2 cells (Fig. 7) as well as in the Fut8 KO C6 cells (Fig. 10), all 
of which could share similar mechanisms. The detailed molecular mechanisms require 
further studies. 
Second, core fucosylation deficiency could down-regulate anti-inflammatory signaling 
(Fig. 11). It is known that microglia can exist in two different states: one is an activated 
state (M1), which is typified by the expression of inflammatory cytokines and reactive 
oxygen species such as NO produced by iNOS; the other is a state of alternative 
activation (M2), which exhibits the properties of an anti-inflammatory phenotype 
involved in the production of interleukin 4 (IL-4), interleukin 10 (IL-10), and TGF-β 
etc., that are implicated in inhibiting inflammation and restoring homeostasis in the 
CNS (64). As described above, the TGF-β-induced Smad2/3 signaling pathway is also 
one of the important anti-inflammatory signaling pathways. Core fucosylation 
differentially regulates the biological functions of receptors. Our previous study showed 
that a lack of core fucose led to a marked reduction in the ligand-binding ability and the 
downstream signaling of several receptors (8, 14, 56). A lack of core fucose in TGF-β 
receptors suppressed its binding with TGF-β and subsequently inhibited its downstream 
signaling such as in the phosphorylation of Smad2/3, which resulted in the development 
of an emphysema-like phenotype in Fut8
-/-
 mice (14, 56). Furthermore, in a cigarette 
smoke-induced emphysema model, the Fut8
+/-
 mice showed a higher inflammatory 
response than that of Fut8
+/+
 mice (8). In this study, coincidentally, we observed a 
modest expression of phosphorylated Smad2 following stimulation with IFN-γ in WT 
BV-2 cells, but this expression was below the detection level in the KO cells (Fig. 7). 
These data suggested that the anti-inflammatory signaling pathways, at least TGF-β 
signaling pathway, could be downregulated in Fut8 deficient cells. 
Third, a lack of core fucose in IgG might also contribute to increased 
neuroinflammation in Fut8
-/-
 mice, because IgG plays an important role in the human 
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immune system, and N-glycans act as a switch between pro- and anti-inflammatory IgG 
functions. As described above, core fucose deficiency in the N-glycans of Fc receptor 
FcγRIIIa expressed on microphages and in the Fc region of IgG dramatically increases 
Fc and Fc receptor binding, which may also partially explain why Fut8
-/-
 mice 
demonstrate a higher state of inflammation.  
Figure 11: A simplified model for core fucosylation on a neuroinflammation model. 
Based on our observations in the present study, loss of core fucosylation could cause 
differences in the regulation of the sensitivities of microglia and astrocytes to stimuli. 
Core fucose deficiency seemed to enhance the pro-inflammatory signaling, such as 
IFN-γ/p-STAT1 and IL-6/p-STAT3 signaling pathways, while decrease the 
anti-inflammatory signaling, such as in the TGF-β/p-Smad2 signaling pathway, which 
has been also observed in lung tissues as well as in fibroblast cells (14). It should be 
noted that only modest changes could be detected in the pro-inflammatory and 
anti-inflammatory signaling levels between WT and Fut8 KO glial cells. Considering 
most cytokine receptors, such as TGF-β receptor and gp130, could be core fucosylated, 
we believe that the concerted responses of these small effects could result in a 
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significant impact in vivo, as observed in Fut8 KO mice as well as in Fut8-deficient 
patients (10, 12, 13).  
 
These studies provide direct evidence for the mechanistic roles of Fut8 in different 
biological processes, where the attachment of core fucose leads to an alteration in the 
glycoprotein conformation, which determines its protein dynamics coupled with the 
selection of protein-protein interactions and complex formation, and consequently 
affects the intracellular signaling pathways. 
In summary, results from the present study clearly showed that core fucosylation exerts 
dual effects in microglia and astrocytes. Deficiency of Fut8 enhanced the 
pro-inflammatory signaling pathways, while inhibited the anti-inflammatory signaling 
pathways (Fig. 11). It should be noted that only modest changes in the pro-inflammatory 
and anti-inflammatory signaling could be detected between WT and Fut8 KO cells in 
this study, but in concerted responses these small effects may result in a big impact in 
vivo, as shown in Fig. 3. Considering the important roles of microglia during brain 
development (65) and the participation of glial cells in schizophrenia (16), and the 
schizophrenia-like phenotype (10) as well as the high rate of mortality (14) found in 
Fut8
-/-
 mice, we concluded that the disorders in CNS with deficient core fucosylation 
may be caused by not only neurons but also by glial cells. 
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